A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients
NCT00201344 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 320
Last updated 2010-03-26
Summary
* To investigate the efficacy of adjuvant PFL chemotherapy after radiotherapy vs radiotherapy alone in AJC stage IV nasopharyngeal carcinoma patients. The endpoints of the study includes : overall survival, relapse free survival, distant metastasis and local-regional control rates.
* To evaluate the toxicities of the two treatment methods.
Conditions
- Nasopharyngeal Carcinoma
Interventions
- DRUG
-
Cisplatin,5-FU,Leucovorin
Sponsors & Collaborators
-
National Taiwan University Hospital
collaborator OTHER -
Tri-Service General Hospital
collaborator OTHER -
Kaohsiung Medical University
collaborator OTHER -
Kaohsiung Veterans General Hospital.
collaborator OTHER -
Taipei Veterans General Hospital, Taiwan
collaborator OTHER_GOV -
Mackay Memorial Hospital
collaborator OTHER -
National Health Research Institutes, Taiwan
lead OTHER
Principal Investigators
-
Kwan-Hwa Chi, MD, · Taiwan cooperative oncology group
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1994-11-30
- Completion
- 2000-01-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain
NCT05304468 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin
NCT02562599 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03020329 ·Status: UNKNOWN ·Phase: PHASE2
-
Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma
NCT03668730 ·Status: UNKNOWN ·Phase: PHASE2
-
Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
NCT03503136 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT04136886 ·Status: RECRUITING ·Phase: PHASE3
-
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC
NCT07332247 ·Status: RECRUITING ·Phase: PHASE2
-
Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma
NCT02786641 ·Status: UNKNOWN ·Phase: PHASE3
-
Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03047265 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
NCT02460887 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients
NCT02973386 ·Status: COMPLETED ·Phase: PHASE3
-
Nedaplatin in Treatment for Nasopharyngeal Carcinoma
NCT04834206 ·Status: COMPLETED ·Phase: PHASE2
-
Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma
NCT02610556 ·Status: UNKNOWN ·Phase: PHASE2
-
Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy
NCT04384627 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal Carcinoma
NCT04764149 ·Status: UNKNOWN
-
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
NCT06092957 ·Status: RECRUITING ·Phase: PHASE3
-
Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma
NCT02871518 ·Status: UNKNOWN ·Phase: PHASE2
-
A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma
NCT07062484 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy Alone
NCT06612697 ·Status: ACTIVE_NOT_RECRUITING
-
Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC
NCT02421640 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
NCT02444949 ·Status: COMPLETED ·Phase: PHASE2
-
Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03919552 ·Status: RECRUITING ·Phase: PHASE3
-
Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma
NCT03177174 ·Status: COMPLETED ·Phase: NA
-
Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients
NCT02604472 ·Status: COMPLETED
-
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT01872962 ·Status: UNKNOWN ·Phase: PHASE3